Tatton-Brown-Rahman syndrome with a novel DNMT3A mutation presented severe intellectual disability and autism spectrum disorder

Tatton-Brown-Rahman syndrome is a congenital anomaly syndrome that manifests with overgrowth, macrocephaly, and characteristic facial features. This autosomal dominant disease is caused by a germline mutation in DNMT3A . Some patients with this syndrome develop mild to severe intellectual disability, which is sometimes accompanied by autism spectrum disorder or other developmental disorders. We report a Japanese patient with severe intellectual disability and autism spectrum disorder with a de novo mutation in the active domain of DNMT3A .

[1]  A. Afenjar,et al.  SETD2 and DNMT3A screen in the Sotos-like syndrome French cohort , 2016, Journal of Medical Genetics.

[2]  S. Seal,et al.  Mutations in the DNA methyltransferase gene DNMT3A cause an overgrowth syndrome with intellectual disability. , 2014, Nature genetics.

[3]  A. V. D. van den Ouweland,et al.  Acute myeloid leukaemia in a case with Tatton-Brown-Rahman syndrome: the peculiar DNMT3A R882 mutation , 2017, Journal of Medical Genetics.

[4]  B. Xin,et al.  Novel DNMT3A germline mutations are associated with inherited Tatton‐Brown–Rahman syndrome , 2017, Clinical genetics.

[5]  M. Shinawi,et al.  The spectrum of DNMT3A variants in Tatton–Brown–Rahman syndrome overlaps with that in hematologic malignancies , 2017, American journal of medical genetics. Part A.

[6]  J. Gauthier,et al.  A case of familial transmission of the newly described DNMT3A‐Overgrowth Syndrome , 2017, American journal of medical genetics. Part A.

[7]  Katrina Tatton-Brown,et al.  Mutations in the DNA methyltransferase gene, DNMT3A, cause an overgrowth syndrome with intellectual disability , 2014, Nature Genetics.

[8]  N. Rahman,et al.  The Tatton-Brown-Rahman Syndrome: A clinical study of 55 individuals with de novo constitutive DNMT3A variants , 2018, Wellcome open research.

[9]  M. Kubota,et al.  Acute myeloid leukemia‐associated DNMT3A p.Arg882His mutation in a patient with Tatton‐Brown–Rahman overgrowth syndrome as a constitutional mutation , 2017, American journal of medical genetics. Part A.